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Abstract
Background: As a group, fibroproliferative disorders of the lung, liver, kidney, heart, vasculature and integument are
common, progressive and refractory to therapy. They can emerge following toxic insults, but are frequently idiopathic. Their
enigmatic propensity to resist therapy and progress to organ failure has focused attention on the myofibroblast–the
primary effector of the fibroproliferative response. We have recently shown that aberrant beta 1 integrin signaling in fibrotic
fibroblasts results in defective PTEN function, unrestrained Akt signaling and subsequent activation of the translation
initiation machinery. How this pathological integrin signaling alters the gene expression pathway has not been elucidated.
Results: Using a systems approach to study this question in a prototype fibrotic disease, Idiopathic Pulmonary Fibrosis (IPF);
here we show organized changes in the gene expression pathway of primary lung myofibroblasts that persist for up to 9
sub-cultivations in vitro. When comparing IPF and control myofibroblasts in a 3-dimensional type I collagen matrix, more
genes differed at the level of ribosome recruitment than at the level of transcript abundance, indicating pathological
translational control as a major characteristic of IPF myofibroblasts. To determine the effect of matrix state on translational
control, myofibroblasts were permitted to contract the matrix. Ribosome recruitment in control myofibroblasts was
relatively stable. In contrast, IPF cells manifested large alterations in the ribosome recruitment pattern. Pathological studies
suggest an epithelial origin for IPF myofibroblasts through the epithelial to mesenchymal transition (EMT). In accord with
this, we found systems-level indications for TGF-b -driven EMT as one source of IPF myofibroblasts.
Conclusions: These findings establish the power of systems level genome-wide analysis to provide mechanistic insights into
fibrotic disorders such as IPF. Our data point to derangements of translational control downstream of aberrant beta 1
integrin signaling as a fundamental component of IPF pathobiology and indicates that TGF-b -driven EMT is one source for
IPF myofibroblasts.
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Introduction
Fibroproliferative disorders are a major cause of morbidity and
mortality [1]. Traditionally parsed into categories based on the
target organ afflicted-lung, liver, kidney, heart, vasculature, CNS
or integument-biomedical scientists now view the fibroproliferative
diseases as sharing a common pathobiology independent of the
organ or tissue that scars [2,3]. Organs can heal or scar following
toxic exposures, with fibrosis predominating when the injurious
agent cannot be eradicated by the host defense system, as occurs
with certain infections; or is repeatedly introduced over a
protracted interval of time as occurs in asbestosis, silicosis or
alcohol-induced hepatic cirrhosis. The clinical focus in these
situations is specific antimicrobial therapy or prevention. More
vexing, however, are the fibroproliferative diseases of unknown
cause, which frequently progress to organ dysfunction or death.
Currently, while there are a few therapeutic leads [4,5], there are
no therapies that reproducibly interdict fibrosis.
For decades, innate and adaptive immunity has served as the
focal point for studies of tissue fibrosis. While an unremitting
immune response can lead to fibrosis, in many idiopathic fibrotic
disorders, immune-suppressive therapy affords limited benefit.
This has shifted attention to the primary effector of the
fibroproliferative response, the fibroblast itself. Fibroblasts from
patients with systemic sclerosis, renal fibrosis, keloids and
pulmonary fibrosis display aberrations in processes that govern
nearly every aspect of the fibroproliferative response
[6,7,8,9,10,11]. These data indicate that fibrotic fibroblasts
manifest pathological control of pathways governing proliferation,
viability, motility, contractile function and connective tissue
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the context of exogenous signals from matrix, cytokines,
chemokines, morphogens and peptide growth factors; fibrotic
fibroblasts appear to retain a distinct cell biology in vitro.
Here we study the fundamental pathobiology of tissue fibrosis by
focusing on a lethal respiratory disorder, idiopathic pulmonary
fibrosis (IPF), as a prototype fibroproliferative disease. The
histological pattern of IPF is usual interstitial pneumonitis (UIP), a
patchy fibroproliferative process that spares some respiratory units
while affecting others nearby. Progression of fibrosis leads to
obliteration of the gas-exchange surface. This pathological respira-
tory phenotype is the culmination of complex interactions among
myofibroblasts, epithelial cells, cytokines, and the surrounding
extracellular matrix. Myofibroblast foci, the pathologic hallmark of
IPF, are comprised of myofibroblasts embedded in a type I collagen
rich matrix [12], and the burden of myofibroblast foci found in lung
biopsy samples inversely correlates with patient survival [13,14,15].
Whereasmyofibroblastsinhealingwoundscontracttheirmatrixand
undergo apoptosis in a timely manner, myofibroblasts in IPF lesions
persist. The mechanism involves aberrant beta 1 integrin signaling
in response to type I collagen. This results in defective PTEN
function and unrestrained Akt signaling leading to downstream
activation of the translation initiation machinery [16]. How this
pathological integrin signaling alters the gene expression pathway of
fibrotic myofibroblasts has not been elucidated.
To answer this question, we took a systems biology approach and
examined two key steps in the myofibroblast gene expression
pathway genome-wide–transcription and ribosome recruitment.
Transcriptional control in IPF has been previously characterized in
lung tissue samples [17]; however, ribosome recruitment pattern-a
measure of which transcripts are being translated into protein-has
not beenexamined in tissue or cell lines. We elected to carry out this
analysis using primary lung myofibroblasts in 3-dimensional type I
collagen gels, an in vitro system that surrounds myofibroblasts in type
I collagen in a context that lacks exogenous cytokines. To simulate
an aberrant, fibrotic environment, we studied cells in type I collagen
gels that were fixed to the sides of a tissue culture dish and therefore
not allowed to contract (referred to as ‘‘non-contractile’’ matrices);
to simulate the environment of physiological healing, we released
the type I collagen gels from the sides of the dish and allowed the
myofibroblasts to contract their matrices (referred to as ‘‘contrac-
tile’’ matrices) [18]. By examining the gene expression pathway of
control and IPF myofibroblasts in both non-contractile and
contractile collagen gels, we are able to determine the extent to
which matrix type and the tissue of origin accounts for any
differences observed at two levels of gene expression regulation.
Here we show distinct intrinsic differences in the gene
expression pathway between control and IPF myofibroblasts in
both non-contractile and contractile type I collagen matrices.
While differences are present at the transcriptional level, the
majority of differences observed are at the level of ribosome
recruitment. Importantly, we demonstrate that IPF myofibroblasts
manifest a much greater dependence on collagen matrix
conditions than do their control counterparts, changing the
translational activity of a large set of transcripts. Our data indicate
that IPF myofibroblasts are intrinsically pathological cells with
fundamental changes in their gene expression pathway primarily
at the level of ribosome recruitment regulation.
Methods
Cell Line Procurement and Characterization
Human primary myofibroblasts from twelve different donors
were utilized (this study was approved by the University of
Minnesota Institutional Review Board for Human Subjects
Research). These consisted of six control samples (histologically
normal lung distant from resected tumor) and six samples from
patients with IPF (histologically confirmed UIP). Tissue was
obtained at the time of biopsy, autopsy, lung resection or lung
transplantation following procedures approved by the University
of Minnesota Institutional Review Board for Human Subjects
Research. Previous work performing microarray analysis on
normal lung tissue[19] has suggested significant differences when
comparing samples from men and women and also when
comparing patients older than 60 years with patients younger
than 40 years of age. Patients in our study were not significantly
different in terms of gender (p=0.43) or age (IPF range 57–68,
control range 56–82, p=0.14) at the time of tissue procurement.
Lung tissue explants were cultivated in 35 mm tissue culture
dishes in explant medium (DMEM+20% FBS+antibiotics and
antimycotics) at 37uC in 95% air, 5% CO2. Outgrowth was
evident in 5 to 7 days, and cells filled the dish in 2 to 3 weeks.
Cells from each 35 mm dish were released with trypsin-EDTA
and placed in 100 mm tissue culture dishes after trypsin was
neutralized with fresh explant medium. These cells, designated
passage 1, were cultivated in growth medium (DMEM+10%
FBS+antibiotics) at 37uC in 95% air, 5%CO2. Medium was
replaced twice weekly, and cells were subcultivated weekly at a 1:4
split ratio. Cells designated myofibroblasts in both IPF and control
samples had typical spindle morphology, were vimentin- and
alpha smooth muscle actin-positive; and factor VIII- and
surfactant C-negative. Cells used in this study were between
passage 4 and 9.
Assessment of Proliferative Uniformity
Myofibroblasts in log phase growth were released from culture
dishes with Trypsin-EDTA, washed, suspended in PBS containing
2.5 mM of the stable vital dye carboxyfluoroscein succinimidyl
ester (CFSE) (Sigma) and incubated at 37uC for 10 minutes
(shaking every 2 minutes). The reaction was stopped with ice cold
PBS. Cells were centrifuged (1000 g) and washed with PBS. The
resultant CFSE labeled myofibroblasts were placed into 6 well
clusters at 40,000 cells/well in growth medium (DMEM+10%
FBS) and cultures continued (37uC, 5% CO2). At the time points
indicated, cells were released from the culture dish and fixed (4%
formaldehyde) prior to analysis by FACS (day 0 cells were
harvested 4 h after seeding).
Collagen Gel Preparation
Collagen was obtained from Cohesion Corporation, Palo Alto,
CA. Cells were removed from tissue culture plates using trypsin
and mixed with DMEM, 10% FBS and collagen (final collagen
concentration 0.5 mg/ml). This mixture was polymerized in a
water bath at 37u C, aliquoted into 3.5 cm tissue culture dishes,
and placed into an incubator at 37u until harvest. Final cell density
was approximately 200,000 cells/ml. Tissue culture plates for non-
contractile gels had been pre-coated with collagen 100 mg/ml in
phosphate-buffered saline (PBS) in order to prevent matrix
contraction. Cells in these non-contractile collagen matrices were
incubated at 37uC for 6 hours. Contractile matrices were prepared
as above; they were allowed to polymerize in uncoated tissue
culture dishes for two hours, and then the gel was released by
tapping the side of the dish. They were placed in an incubator for
four more hours before harvesting (for a total 6-hour incubation
time, equal to non-contractile matrices). Degree of collagen matrix
contraction was not significantly different between IPF and control
myofibroblasts (data not shown).
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Cells were harvested in log phase using trypsin and incorporated
into collagen gels as described above. Myofibroblasts were
collected from the gels at the predetermined time point using
collagenase 5 mg/ml (Sigma, St. Louis, MO) containing cyclo-
heximide (100 mg/ml) and collected by centrifugation. A small
portion of non-homogenized cells was retained for Trireagent
(Sigma) processing to isolate total cellular RNA (designated ‘‘total
RNA’’) for microarray analysis. The remaining cells were used for
polyribosome preparations as described [20]. Ten 0.5 ml fractions
were collected from each sample into tubes containing 50 mlo f
10% SDS. RNA from each fraction was processed using
Trireagent according to the manufacturer’s directions and
precipitated with isopropanol. Fractions 7–10, consisting of
mRNA with four or more bound ribosomes, designated ‘‘heavy’’,
were pooled for microarray analysis.
Microarray Hybridization
Starting with 10 mg of ribosome-bound or total RNA,
conversion to labeled cRNA was performed using the One Cycle
Target Labeling and Control Reagent Kit according to the
manufacturer’s directions (Affymetrix Corp., Santa Clara, CA).
Labeled fragmented cRNA (20 mg) was submitted to the
University of Minnesota Biomedical Genomics Center and probed
with Affymetrix U133plus2 microarrays.
Quantification of mRNA by Real Time PCR
A new set of polyribosome RNA preparations, different from
those used to perform the microarray analysis, was used for real
time PCR. We chose one IPF and one control myofibroblast
primary cell type for this set of experiments. RNA from each
fraction of the sucrose gradient was extracted using Trireagent and
quantified. An internal standard, ‘‘alien RNA’’, was spiked into
each sample to control for differences in cDNA conversion
efficiency as described in the instructions for the AlienH QRT-
PCR Inhibitor Alert kit (Stratagene, LaJolla, CA). cDNA was
synthesized from 2.0 mg of each fraction using Taqman Reverse
Transcriptase Reagent Kit (Applied Biosystems, Foster City, CA)
primed with oligo dT. Primer sequences for selected genes were
selected using the DNASTAR program (DNASTAR, Inc.,
Madison, WI), and the resulting sequences were synthesized in
the University of Minnesota microchemical facility. Real time
PCR was performed using a LightCycler FastStart DNA
Master
PLUS SYBR Green I Kit (Roche Diagnostics, Indianapolis,
IN). 2.5 ul of the cDNA product was used for amplification of each
sample. Primer sequences were as follows: CFL2 forward 59GGA
CCG TTC GAC ACT TGG AGA39 CFL2 reverse 59AAT GGA
CTG AGC TGG AGA AAT GG39; PDCD8 forward 59CAG
CGA TGG CAT GTT CCT CTA3; PDCD8 reverse 59ACG
CGG CCT TTT TCT GTT TCT39; FUT10 forward 59AGC
AGC GCG AGA GTA GAA GTG AAT39; FUT10 reverse
59CAG TAG ATG CCC CAG ACA GGA GAG39. Samples were
quantified at the log-linear portion of the curve using LightCycler
analysis software and compared to an external calibration
standard curve. Each sample was normalized for cDNA
conversion efficiency using the external ‘‘alien control’’. The total
RNA samples were normalized using b-actin. b-actin primer
sequences were: forward 59 CTG GAA CGG TGA AGG TGA
CA 39, reverse 59 AAG GGA CTT CCT GTA ACA ATG CA 39.
Western blotting
Cells were grown to 70% confluence and serum starved for
48 hr. Cells were released with trypsin and seeded onto 100 mm
dishes that were pre-coated for 1 hr with Pur-Col monomeric
collagen 100 ug/ml in PBS (Allergan Sales Inc.). Cells were
allowed to adhere for 75 min, mechanically released and
resuspended in lysis buffer (40 mM tris pH 7.5, 300 mM NaCl,
2 mM EDTA, 100 mM NaF, 2% NP-40, 1% Na Deoxycholate,
supplemented with ‘‘Complete’’ protease inhibitor tablets
(Roche)). Lysates were kept on ice for 10 min, centrifuged at
12,000G for 10 min with supernatants retained and subjected to
electrophoresis and Western blotting with antibodies for Keratin
18, PDCD8 and CFL2 from Cell signaling (Boston, USA); FUT10
from Abcam (Cambridge, USA); and b-actin from Sigma (USA).
Data analysis
Totally 12 samples (6 IPF and 6 controls) informed the study.
From each sample we obtained the polyribosome bound (4 or
more bound ribosomes) and total RNA under the two conditions
under study, thus totally 48 hybridizations. The data was
normalized using GCRMA and updated probe sets definitions
‘‘RefSeq v7’’ as defined in [21] as these provide improved
precision and accuracy [22]. We used the Significance Analysis of
Microarrays (SAM) algorithm implemented in R ‘‘samr’’ v1.24 to
identify differentially expressed genes using an un-paired or paired
approach as applicable (thus when comparing within cell lines,
non-contractile vs. contractile from the same donor, a paired test
was used, otherwise we used a non-paired test). We further used a
fixed s0=0.1, a large delta table (400) and a fixed random seed
(1,2,3,4,5,6,7,8,9) [23]. Only genes that were classified as present
in at least 6 samples (in the studied comparison) using the present
absent algorithm from MAS5 implemented in the ‘‘affy’’ package
in R, were used as input as this reduced the noise [24]. We used
GO::Termfinder v0.72 [25] to identify gene ontologies that were
overrepresented in the generated gene lists and considered all with
an False Discovery Rate (FDR),15% significant (using simulation
significances implemented in GO::Termfinder).
Study of pathway activity
To test whether selected pathways were active in a specific
comparison we sought to identify enrichment of genes within a
pathway at the extreme ends of a ranked gene list. First all
measured genes were ranked according to their transcription and
translational ‘‘d-scores’’ (obtained from a SAM run including all
available genes) comparison by comparison. We used a ‘‘step
down’’ approach to test for enrichment of genes within the
pathways from each end of the ranked gene list. First the range of
statistics between the highest and lowest 1% d-scores was used to
create 40 bins. Exclusion of the extreme 1% avoided outlier
statistics from dominating the definition of the bins. For each
pathway, we used Fisher’s exact test to look for enrichment of
genes until a given bin, compared to the total number of genes in
the pathway-and the data set (thus first looking at the top 1% and
then stepping down bin by bin). The analysis was performed both
from the top and bottom of the ranked gene list, thus assessing
activity of the pathway in the IPF and the control group. This
generated matrixes of p-values and odds ratios for each pathway
and from each direction. As many p-values were generated, we
corrected for multiple testing using Benjamin & Hochsberg
multiple correction (implemented in fdrtool for R) of all p-values,
from the pathways included in the analysis. To summarize the
data across all pathways and studies in a matrix, we created a
discrete output so that [significant overrepresentation from the
top] (1), [significant overrepresentation from the bottom] (21), [no
significant overrepresentation] (0) or [significant overrepresenta-
tion from both top and bottom] (2) was indicated in each
comparison to pathway interaction. Pathways showing an
Translational Control in IPF
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the same time, and therefore the correction for multiple testing
accounted for all modules tested. This approach is similar to [26].
Results
Selection of time point for global analysis of transcription
and ribosome recruitment
Three-dimensional collagen gels have been used to simulate
tissue repair [27]. Because type I collagen is the most abundant
matrix component in the lung interstitium, collagen gels are a
useful in vitro model to investigate the molecular pathways
regulating lung myofibroblast function. We previously showed
that normal lung myofibroblasts cultured in contractile collagen
gels undergo apoptosis as they contract the matrix, whereas
myofibroblasts within non-contractile matrices remain viable
[28,29,30,31]. To ensure we were studying gene expression in
viable cells, we sought a time point when differences in the
intrinsic myofibroblast phenotype could be assessed independent
of cell death; we used stability of ribosome loading onto RNA as
the viability metric. Within 2 hours of seeding myofibroblasts into
gels, cells attached and spread (observed by phase contrast
microscopy–data not shown). After 4 additional hours, polyribo-
some tracings from IPF and control myofibroblasts in contractile
and non-contractile collagen gels showed no global shift in
ribosome loading (Figure 1); this time point (6 h post-seeding) was
therefore selected for genome-wide assessment of transcription and
ribosome recruitment to RNA.
Genome-wide assessment of transcriptional and
translational profiles identifies large changes at the
translational level in IPF myofibroblasts
We carried out a genome-wide analysis of transcript abundance
and ribosome recruitment in primary lung myofibroblast lines
derived from 6 patients with IPF and 6 patient controls. Transcript
abundance was quantified using total RNA while assessment of
ribosome recruitment was performed using RNA associated with
more than 3 ribosomes (isolated using polyribosome RNA
preparations as described previously [32,33]) genome wide using
microarrays. To assess whether there were intrinsic differences
between IPF and control myofibroblasts, we analyzed transcript
abundance and ribosome recruitment in both contractile and non-
contractile collagen matrices. We characterized the extent of
differential regulation of transcription (i.e. transcript abundance)
and translation (i.e. ribosome recruitment) between control and
IPF myofibroblasts by monitoring the cumulative number of genes
passing a range of significance thresholds using both the
Significance Analysis of Microarrays (SAM) algorithm and
Student’s t-test. We considered the possibility that the variance
in the data sets generated from polyribosome RNA and total RNA
might differ (so that data derived from polyribosome RNA would
contain more technical noise due to increased sample processing).
In this scenario SAM offers the best estimate of the magnitude of
regulation since the internal data set variance directly influences
the significance estimates through the sample permutation strategy
built into this approach. This is in contrast to fold changes in
which increased data set variance can randomly produce more
extreme fold-changes. We used three different data inputs: i) data
derived from total RNA, ii) data derived from the translationally
active (i.e. polyribosome-associated) RNA pool and iii) transla-
tional data that had been corrected for total RNA abundance by
taking the ratio of (transcript abundance in the actively translated
pool)/(total transcript abundance) cell line for cell line. At each
significance level, more genes differed between IPF and control at
a translational than at a transcriptional level in both contractile
and non-contractile gels (Figure 2). It is important to note that the
transcriptionally corrected translational regulation also showed
more significant regulation compared to the total RNA analysis.
This finding indicates that the difference between the translational
and the transcriptional regulation cannot be explained by higher
data set variance for the total RNA data sets (as the fold differences
in the translational estimate have been normalized to the fold
differences in the transcriptional estimate and therefore contain
the variance from both of these comparisons). This corrected
analysis will underestimate the translational regulation as a result
of the added variance from both the transcriptional and
translational data. We also directly compared the data set variance
and fold change distribution in these data sets (Figure S1). As
expected, the polyribosome data sets showed higher variance
(presumably due to the multi-step sample preparation) and also
more genes with extreme fold-changes. Since differences in data
set variance are controlled in the SAM algorithm, we conclude
that there is substantial translational deregulation in IPF
fibroblasts compared to controls that cannot be explained by
transcriptional regulation.
To identify a set of differentially expressed genes that we
considered significant, we used SAM and collected genes with a
False Discovery Rate,15% using transcription data and data
derived from the translationally active pool. Differences in
transcript abundance between IPF and control were modest
among the more than 15,000 measured genes. In non-contractile
collagen matrices, 23 named, unique genes displayed statistically
significant transcriptional differences; and in contractile collagen
matrices 41 named, unique genes differed. In contrast, translation
differed sharply between IPF and control. In non-contractile gels
we identified 1346 named, unique genes showing significantly
different ribosome recruitment, and in contractile gels there were
488 genes that differed (See Tables S1, S2, S3, S4 for full list of
transcriptionally and translationally regulated genes in both
contractile and non-contractile condition).
To compare the regulation patterns of genes found to be
differentially expressed in any comparison (contractile, non-
Figure 1. Representative polyribosome tracings from control
and IPF myofibroblasts in non-contractile collagen matrices.
Shown is OD 254 as a function of position in the sucrose gradient. The
fractions pooled to yield the heavy polyribosomes and total RNA are
designated
doi:10.1371/journal.pone.0003220.g001
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such genes (not only those genes that were named) and compared
both the significance levels and the fold changes (Figure 3, and
Table S5). The analysis indicates that there is a large set of genes
that are regulated at the translational level whose differential
expression cannot be appreciated at the transcriptional level (see
both the q-value analysis and the fold-change analysis in Figure 3)
in both the contractile and the non-contractile state. In accord
with the data presented in Figure 2, this fraction of genes is larger
than the fraction for which regulation at the translational and
transcriptional level is congruent (i.e. no translational regulation).
These data demonstrate that IPF myofibroblasts differ from
control primarily at the level of ribosome recruitment and that
these differences are apparent in a non-contractile matrix
simulating fibrosis, and persist in a contractile collagen matrix
that simulates normal healing.
Validation of differential ribosome recruitment
While the combined polyribosome-microarray approach has
been used and validated in established cell lines [32,34,35,36], we
wanted to test its validity in primary cells. For validation of
polyribosome microarray data it is common to trace the profile of
the gene of interest using quantitative real time PCR (qRT-PCR)
across the fractions of the polyribosome gradient. Regulation is
identified as a shift towards fractions with more or fewer ribosomes
depending on the direction of regulation. To do this, we identified
two cell lines, one control and one IPF (new cell lines not part of
the initial microarray study); that were available at a sub-
cultivation number identical to that used in the microarray
experiments and in sufficient quantity to generate enough mRNA
for qRT-PCR from each fraction (an independent validation with
new cell lines). We randomly selected one gene shown by our
analysis to manifest increased ribosome recruitment in IPF
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Figure 2. Number of genes passing significance thresholds. Shown are t-test and SAM statistics of the cumulative number of genes passing
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(CFL2) and one that did not differ between IPF and control
(FUT10). We performed qRT- PCR across the polyribosome
fractions for these three genes in both IPF and control to assess the
translational activity and measured total RNA levels to assess
transcriptional regulation. For the regulated genes, the expected
shift in polyribosome profile was observed (PDCD8 shifted
towards higher fractions in IPF (Figure 4A); CFL2 shifted towards
lower fractions in IPF (Figure 4B); and the negative control
(FUT10) displayed a similar pattern in IPF and control
(Figure 4C)). The total RNA level was similar for each gene in
IPF compared to control (Figure 4D).
In general, increased ribosome loading is expected to lead to
increased steady state levels of the encoded protein. To assess this
relationship between ribosome recruitment and protein level, we
performed immunoblot analysis of PDC8, CFL2 and FUT10 from
the cells used for polyribosome qRT-PCR validation in Figure 4A–
D. In accord with the polyribosome microarray data and the
polyribosome qRT-PCR validation, immunoblot analysis showed
that IPF myofibroblasts had increased PDC8 protein levels,
decreased CFL2 levels and similar FUT10 levels compared to
control (Figure 4E).
To expand our validation set, we identified 6 additional primary
fibroblast lines (3 IPF and 3 control, which were part of the initial
microarray study) that matched the sub-cultivation criteria for the
original array analysis and assessed steady state protein levels for
PDCD8, CFL2 and FUT10 (this requires substantially fewer cells
than is needed for polyribosome preparations) (Figure 4F). For the
cell lines assessed in Figure 4F, there was a mean increase in
PDCD8 protein level of 1.5 fold in IPF. When also including the
cell lines validated in Figure 4E, 6 out of 8 cell lines confirmed that
the PDCD8 protein is more abundant in IPF. For CLF2, a similar
analysis indicated a 2-fold mean difference in protein level in
Figure 4F with all 8 cell lines from Figure 4E–F confirming the
direction of regulation (higher in control). For FUT10 there was
no mean difference (1.1 fold higher in IPF) in Figure 4F.
To assess the significance of the validation, we used the
binomial distribution in which the expected pattern can either be
confirmed or not between a pair of IPF and control cells (using
data from 4E–F). For PDCD8 and CFL2, 7 out of 8 theoretical
IPF and control pairs followed the expected pattern of regulation
with 4 comparisons for CLF2 showing higher levels in control and
3 comparisons for PDCD8 showing higher levels in IPF. One pair
for PDCD8 showed an opposite pattern of regulation with the
control higher than IPF (note that we have used the most
disadvantageous construction of pairs to obtain one failed pair).
Using the binomial distribution to calculate the probability of
finding 7 or more confirmed patterns of regulation out of 8
(assuming a 0.5 probability for success in each trial) , we observed
a successful validation with a p-value of 0.035. If we include the
additional validation of Keratin 18 (below), we observed a
successful validation with a p-value of 0.006 (10 out of 11). Thus
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Figure 3. A comparison of translational and transcriptional regulation. All genes that were classified as differentially expressed (translational
or transcriptional level) between IPF and control were collected. The differential regulation at the transcriptional (‘‘Total’’) or translational (‘‘Heavy’’)
were compared in the non-contractile (A–C) and contractile (D–F) state. Significance level (log2 q-value (%)) (A, D) and fold changes (log2) (B–C, E–F)
were used for comparison. The lines in the comparison of significances (A, D) indicate a q-value of 15% (3.9 on the log2 scale). The lines in the
comparisons of fold changes indicate a 1.5 fold change (B, E) and a 2 fold change (C, F). The number of genes what fall within each sector is indicated.
Higher fold changes and lower significances indicate differential regulation.
doi:10.1371/journal.pone.0003220.g003
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PLoS ONE | www.plosone.org 7 September 2008 | Volume 3 | Issue 9 | e3220our data reflect authentic differences at the ribosome recruitment
step of gene expression regulation which corresponds to changes in
protein level.
Collagen matrix state modulates translational activity
We next examined the direction of change among the
translationally regulated genes. Of the 1346 genes with a
significant translational shift in non-contractile collagen matrices,
surprisingly only 138, or 10%, were relatively more active in IPF
myofibroblasts compared with controls. However, of the 488
unique genes showing significant translational differences in
contractile collagen matrices, 348, or 71%, exhibited greater
ribosome loading in IPF myofibroblasts than in controls (see Table
S1, S2) These data indicate that collagen matrix state modulates
translational activity.
Our findings also indicate that at least one of the cell types must
undergo extensive translational regulation in a matrix-dependent
manner. To assess which of the cell types gave rise to this effect, we
compared control and IPF myofibroblasts on both matrices. When
examining translation in non-contractile vs. contractile collagen
matrices, we found more than 3-fold unique, named genes
differing at the level of ribosome recruitment in IPF myofibroblasts
compared to control myofibroblasts (1753 vs. 575). Very few
significant differences were found when analyzing transcriptional
data in the same manner–just 26 genes differed in the IPF
myofibroblasts and no genes differed in controls when comparing
non-contractile vs. contractile matrices. This analysis shows that
IPF cells undergo large scale translational regulation depending on
matrix state, while control myofibroblasts show relative stability at
this level of gene regulation.
Systems analysis of myofibroblast function and origin
Comparisons of genes that differ between IPF and normal
myofibroblasts could give important information about IPF
biology. Such an assessment could be done at a single gene level
or by studying the activity of groups of genes organized into
pathways. When comparing the single gene approach and the
‘‘gene set’’ or ‘‘module’’ approach, modular analysis has the
advantage of giving more biological information and providing a
far more robust statistical environment. We therefore used both
approaches to study the biology of IPF.
The gene ontology consortium[37] has developed a system for
classifying biological information that has been extensively used to
categorize and analyze microarray data. We used this organiza-
tional scheme to examine genes classified as differentially
expressed at the translational level (too few genes were identified
at the transcriptional level to provide a meaningful analysis). One
comparison (more active in controls in contractile matrices)
resulted in no significant functions (FDR,15% was used as a
significance threshold). Two other comparisons (more active in
IPF in contractile matrices and more active in IPF in non-
contractile matrices) resulted in several significant functions. These
included membrane and vesicle transport functions in the non-
contractile state and membrane and metabolism (primarily
carbohydrate, protein and glycoprotein synthesis) in the contractile
state (Table S6, S7). In the final analysis of genes that were more
active in control compared to IPF myofibroblasts in the non-
contractile state, we found a striking enrichment of genes involved
in cell cycle regulation (Table S8). These genes included both
positive and negative cell cycle regulators, indicating that
translational control of cell cycle regulation differs between IPF
and control; a result in accord with the current literature
[38,39,40,41]. Thus this functional analysis indicated that
depending on matrix state, different functions differentiated IPF
from controls at the translational level.
One possible explanation for the differences observed regarding
cell cycle regulation is that we are studying myofibroblast
populations or subpopulations that have begun to enter cellular
senescence. This concern emerged from our observation that IPF
myofibroblasts showed morphological changes characteristic of
senescence [42] at an earlier passage than did controls (data not
shown). While our experiments employed cells several passages
before any morphological senescence was observed, we wanted to
investigate whether differences between IPF and controls in our
analysis could be attributable to IPF cells just beginning to enter
senescence. We therefore compared our microarray data to a data
set describing a meta-signature from senescent cells apparent
across many cell types and species [43]; we found no indication for
senescence in our primary cell lines.
As another explanation of the differences between IPF and
control myofibroblasts, we considered the possibility that a small
subpopulation of rapidly proliferating cells could dominate the
results. To address this issue, we applied a technique commonly
used in immunology to track the proliferation of subpopulations of
lymphocytes and labeled our myofibroblasts with the stable vital
dye, carboxyfluoroscein succinimidyl ester (CFSE) [44]. Uniform
proliferation on a population level can be observed as Gaussian
distribution whose mean CFSE signal is decreased by approxi-
mately 50% per cell division. Using this procedure, we determined
that cell proliferation was uniform in all IPF and control cell lines,
with an approximate doubling time of 1 day. There was neither a
rapidly nor a slowly proliferating subpopulation in any of the cell
lines studied (Figure S2).
The conventional systems approach we employed to analyze
our gene lists has important limitations that arise from its
dependence on finite lists of individual genes that pass an arbitrary
significance threshold. Such lists are dominated by well-expressed
genes experiencing large changes. These lists do not take into
account biologically important genes that may barely-or even fail
to-pass a significance or fold-change threshold, but nevertheless
are critical components of a physiological process that my be the
crux of the pathobiology under study [45]. It is therefore
important to supplement these conventional analyses with
methods that are not dependent on finite lists of significant genes.
We therefore used a modular approach that has proved useful
in prior studies of translational control [45]. All genes were
ordered based on relative transcriptional or translational activity in
IPF compared to control myofibroblasts, as described in Materials
and Methods. We looked for over-representation of genes
belonging to selected pathways at the extreme ends of the ordered
Figure 4. Validation of genome-wide data. Three genes were selected: Programmed Cell Death 8 (PDCD8) which demonstrated more ribosome
loading in IPF; Cofilin 2 (CFL2) which showed more ribosome loading in controls; and Fucosyltransferase 10 (FUT10) which displayed no change in
ribosome loading between the two cell types. A–C. Polyribosome shift using qRT-PCR. Shown is the quantity of mRNA normalized to a spike in
standard, as a function of position in the sucrose gradient. D. Total RNA levels. The total RNA was normalized to a ‘‘spike in’’ standard and actin. E–
F. Steady state protein levels of PDCD8, CFL2 and FUT10. Cells (passage 5) were seeded on type I collagen matrices and examined for protein
expression using actin as a loading control E. Western blotting from the same cell lines as in (A–D). F. Steady state levels of 6 additional primary
myofibroblast lines (3 IPF; and 3 control).
doi:10.1371/journal.pone.0003220.g004
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PLoS ONE | www.plosone.org 8 September 2008 | Volume 3 | Issue 9 | e3220list, thus assessing increased or decreased activity of the pathway in
IPF compared to control myofibroblasts. It should be noted that
these pathways are different than the GO-collection studied above
except for 4 modules as indicated in Figure 5; and that the
significance levels were corrected for multiple testing taking into
account all analyses presented in Figure 5. We selected all
published pathways available for cell signaling (found on the web
at http://www.genome.ad.jp/kegg), and detected significant
differences in pathway activities at the level of transcript
abundance and ribosome recruitment (Figure 5). Some pathways,
such as transforming growth factor (TGF) and actin regulation,
have established roles in fibrotic processes. Others, such as
wingless (Wnt) or calcium signaling, are less commonly associated
with fibrosis but may lead to novel insights into the disease process.
We also observed regulation of apoptosis and proliferation at both
the transcriptional and translational level. The observed differen-
tial regulation of proliferation motivated us to further examine cell
cycle regulation using data from additional sources and we
collected several categories from GO that describe proliferation.
However, only the ‘‘cell cycle arrest’’ pathway was more active in
IPF compared to normal myofibroblasts. Thus by using curated
pathways and genome-wide data, we find support for a
pathological myofibroblast phenotype in IPF that persists in vitro
up to 9 sub-cultivations. It is noteworthy that this phenotype is
manifest at both levels of gene regulation examined as well as in
several biological pathways.
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PLoS ONE | www.plosone.org 9 September 2008 | Volume 3 | Issue 9 | e3220One critical question amenable to a systems level approach is
the origin of the IPF myofibroblast. The epithelial to mesenchymal
transition (EMT) is a key process during embryonic development
that has been implicated as a source of pathological myofibroblasts
in renal fibrosis and IPF [46,47,48]. To examine whether there
was genome-wide indication for EMT at the level of transcription
and/or translation, we manually constructed a module comprised
of 111 genes that had at least one published study documenting its
participation in EMT, and built 4 sub-modules to represent the 3
major cell surface receptor-mediated pathways triggering EMT
(Wnt, TGF-b and integrin-matrix) and a module comprised of
EMT-related transcription factors (module gene lists provided in
Table S9; these modules were not assessed in the ‘‘significant gene
list analysis’’ presented above). The global EMT module was not
active in IPF compared to control (Figure 5). When studying the
subgroups the TGF-b -EMT module, the integrin-matrix-EMT
module and the transcription factor module distinguished IPF
from control–primarily at the level of transcript abundance. The
analysis shown in Figure 5 was corrected for multiple testing, and
thus the corrected significance level (q,0.05) considers all tests
performed in this part of our study. As a result, p,0.001 was
necessary to reach a corrected significance level of q,0.05. These
data support the contention that EMT is involved in the genesis of
some IPF myofibroblasts, and show the power of this systems level
analysis.
To test the biological validity of this systems level analysis
implicating EMT in the origin of IPF myofibroblasts, we selected
the epithelial intermediate filament component, Keratin 18, for
further analysis. In our genome-wide analysis of ribosome
recruitment, we found that this epithelial gene was dramatically
translationally activated in IPF myofibroblasts compared to
controls. To verify this we used the same samples and approach
as in Figure 4A–C to assess the level of Keratin 18 mRNA across
the polyribosome fractions. Figure 6A shows that Keratin 18 was
indeed more translationally active in IPF compared to control.
Keratin 18 was also marginally increased at the total RNA level
(,1.5 fold, not shown). Nonetheless, to rule out transcriptional
regulation as a primary source of the translational difference, we
corrected the translational profiling data for total RNA levels. This
did not influence the shift towards translational activation in IPF
(not shown). To assess Keratin 18 expression in a panel of cell
lines, we used the same samples as in Figure 4F (i.e. independent
samples from 3 IPF and 3 control fibroblast lines which were part
of the microarray study) and measured protein abundance by
immunoblot (mammary epithelial cells served as a positive control,
Figure 6B). In accord with the genome-wide study and the
polyribosome qRT-PCR validation, Keratin 18 displayed an
increase in protein abundance (Figure 6B) in IPF myofibroblasts
compared to controls. These data indicate that our approach is
biologically valid, and lends further support for the idea that EMT
is involved in the origin of IPF fibroblasts.
Discussion
Myofibroblasts from fibrotic lesions manifest pathological control
of proliferation, viability, motility, contractile function and connec-
tive tissue production. In a prior report, we provided the first
insights into molecular mechanism, showing that aberrant beta 1
integrin signaling results in defective PTEN function, unrestrained
Aktsignalingand downstream activation of the translation initiation
machinery [16]. Here, we provide the first genome-wide analysis of
the consequences of this aberrant signaling. We find that two steps
in the flow of genetic information–transcription and ribosome
recruitment-are altered in IPF myofibroblasts, and that changes in
ribosome recruitment account for the majority of differences
between IPF and control myofibroblasts. When comparing gene
expression in contractile and non-contractile matrices, IPF
myofibroblast gene expression showed large-scale translational
changes depending on matrix state, whereas the pattern in control
myofibroblasts was relatively stable. In addition, our analysis
provides systems level evidence for EMT as a source of some IPF
myofibroblasts, providing strong support for the pathological study
suggesting an epithelial origin for some IPF myofibroblasts [47].
Our data do not exclude the possibility that other IPF myofibro-
blasts may originate from cytokine altered resident fibroblasts or
from circulating fibrocytes. These findings do, however, establish
the power of systems level genome-wide analysis to provide
mechanistic insights into IPF, and point to derangements of
translational control downstream of defective integrin signaling as
a fundamental component of IPF pathobiology.
The clinical outcome of IPF is the result of complex interactions
among myofibroblasts, epithelial cells, cytokines, and the sur-
rounding extracellular matrix. Significant debate continues as to
what degree, or even whether, an abnormality in any individual
component contributes to the overall disease process. Part of this
uncertainty relates to conflicting results found in studies of IPF
myofibroblasts. As an example, investigators comparing prolifer-
ation and apoptosis between IPF and control myofibroblasts have
reached contradictory conclusions[38,39,40,41]. While many
aspects of the debate are not resolved by the results of this study,
there is no doubt that these key processes are fundamentally
different in IPF and control myofibroblasts.
Figure 6. Keratin 18 is translationally activated in IPF myofibroblasts. A. Polyribosome shift using qRT-PCR. Shown is the quantity of
mRNA normalized to a ‘‘spike in’’ standard, as a function of position in the sucrose gradient. B. Steady state protein level. Cells (passage 5) were
seeded on type I collagen matrices and examined for protein expression using actin as a loading control.
doi:10.1371/journal.pone.0003220.g006
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PLoS ONE | www.plosone.org 10 September 2008 | Volume 3 | Issue 9 | e3220Our study demonstrates this fundamental difference in a
comprehensive microarray analysis of two levels in the gene
expression pathway–transcription and ribosome recruitment. A
few previous studies have been performed using microarray
technology to compare transcriptional profiles of IPF and control
myofibroblasts [49,50]. Microarray analysis has also been done
using whole lung samples from patients with IPF, hypersensitivity
pneumonitis (HP), nonspecific interstitial pneumonitis (NSIP) and
controls [17,51,52]. However, all of these investigations focus on
differences in mRNA abundance, which correlates poorly with
protein levels [53,54]. Analysis of translation, the next step in the
processing of genetic information, reveals more prominent and
informative differences between cells, and correlates more closely
with protein levels [32,34]. Consistent with these data, our study
demonstrates markedly more genes differing between IPF and
control myofibroblasts at the level of ribosome recruitment
compared with mRNA abundance. Our study is also the first to
perform this analysis using primary cells rather than immortal,
established cell lines.
Analysis of the stability of the transcriptional and translational
profiles between IPF and control as a function of matrix state
revealed major differences. Control myofibroblasts demonstrated
no significant differences in transcript abundance and relatively
few differences in ribosome recruitment on non-contractile
compared to contractile matrices. In contrast, IPF myofibroblasts
displayed extensive changes in transcription and ribosome
recruitment as matrix state changed. This analysis illustrates a
difference in phenotype between IPF and control myofibroblasts,
suggesting that in IPF there is pathologic relaxation of the gene
expression control system found in normal cells. Furthermore,
these data fit with the idea that IPF myofibroblast pathobiology
includes a loss of translational control, analogous to the loss of
tumor suppressor function seen in cancer. Experimental precedent
for this concept has been provided by studies showing that IPF
myofibroblasts have acquired at least one cancer-related property–
the ability to grow in an anchorage-independent manner [55].
Given the growing body of experimental work indicating that
fibrotic myofibroblasts have a distinct phenotype, one topic that
has recently garnered much interest is the source of myofibroblasts
in IPF. Published morphological data suggest that myofibroblasts
in IPF have an epithelial origin [56]; and there is direct
experimental data implicating EMT as a source of myofibroblasts
in a mouse model of lung fibrosis [47]. Using a systems approach
to analyze genome-wide data, we establish that myofibroblasts
cultured from the lungs of patients with IPF have an EMT
signature. At least 3 pathways can trigger EMT. Here we group
genes associated with each of the 3 EMT pathways, and find that
two of the pathways (matrix and TGF) are active in IPF
myofibroblasts–providing the first systems-level indication regard-
ing mechanism. In accord with this result, recent data indicates
that myofibroblast contraction of its extracellular matrix can
trigger release of TGF- b from its latent form in the matrix [57].
In this report, we demonstrate a difference in transcript
abundance and ribosome recruitment for a number of genes
when comparing myofibroblasts from patients with IPF to
controls. We chose a systems biology approach rather than a
‘‘reductionist’’ or ‘‘cherry picking’’ method to analyze our data
[45,58]. We show instability in the translational profile of IPF
myofibroblasts when they are placed in different matrix environ-
ments, and we present genome-wide data that provide indications
for EMT as a source of myofibroblasts in IPF. We anticipate these
data, along with more intensive investigations of primary cell lines,
will yield important information and significantly impact the
search for new molecular targets for therapeutics.
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